Massive effects on gene expression
Feb 12, 2026 What if the problem with your semaglutide results is not the peptide at all, but how you prepared it
The COA should include HPLC purity data (target: 98% or higher), mass spectrometry confirmation of molecular identity, and ideally, endotoxin testing results
It is not intended for human consumption, therapeutic use, or as a food or drug product
In our opinion, when considering a new compound for clinical testing, it is important to have in vivo and in vitro studies confirming positive effects suggested by gene profiling as well as safety
This variability can affect research results and safety when used outside of controlled laboratory settings